logo-loader

Tony Locantro on the zinc exploration bubble and growth in Imugene's valuation

Published: 10:42 20 May 2021 AEST

Alto Capital's Tony Locantro discusses the recent growth in Imugene Ltd's (ASX:IMU) (OTCMKTS:IUGNF) market capitalisation - currently at $1.75 billion - and says CEO Leslie Chong has done a great job in lifting its valuation. Locantro also talks Chimeric Therapeutics Ltd (ASX:CHM), Rumble Resources Ltd (ASX:RTR), Alta Zinc Ltd (ASX:AZI) , Mako Gold Ltd (ASX:MKG) and where to from here for Bitcoin.

Imugene with Proactive at ASX Small and Mid Cap Conference

Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO and managing director Leslie Chong chats with Proactive's Jonathan Jackson live from the ASX Small and Mid Cap Conference in March 2024. The biotech stock is a clinical-stage immuno-oncology company that's developing a range of new and novel immunotherapies...

1 day, 10 hours ago